These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 668390)

  • 1. Identification of beta-aspartylglycine in uremic serum and its toxicity.
    Gejyo F; Kinoshita Y; Ito G; Ikenaka T
    Contrib Nephrol; 1978; 9():69-77. PubMed ID: 668390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of beta-aminoisobutyric acid in uremic serum.
    Gejyo F; Kinoshita Y; Ikenaka T
    Clin Chim Acta; 1976 Aug; 70(3):407-15. PubMed ID: 947634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and identification of urinary beta-aspartyl dipeptides and their concentrations in human urine.
    Tanaka T; Nakajima T
    J Biochem; 1978 Sep; 84(3):617-25. PubMed ID: 31358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Aspartylglycine, a substance unique to caecal contents of germ-free and antibiotic-treated mice.
    Welling GW; Groen G
    Biochem J; 1978 Dec; 175(3):807-12. PubMed ID: 570395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of serum levels of beta-aminoisobutyric acid in uremic patients and the toxicity of the amino acid.
    Gejyo F; Kinoshita Y; Ikenaka T
    Clin Nephrol; 1977 Dec; 8(6):520-5. PubMed ID: 598058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Fate of β-Aspartyl-(14)C-glycine in Normal Young Rats.
    Tanaka H; Noutomi K; Akiba M; Nishi H
    Biosci Biotechnol Biochem; 1992 Jan; 56(4):644-7. PubMed ID: 27280663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of D-aspartic acid in the novel dipeptide beta-aspartylglycine isolated from tissue extract of Aplysia kurodai.
    Sato M; Yamaguchi T; Kanno N; Sato Y
    Biochem J; 1989 Oct; 263(2):617-20. PubMed ID: 2597124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of the novel dipeptide beta-aspartylglycine by Aplysia ganglia.
    McCaman MW; Stetzler J
    J Neurochem; 1985 Sep; 45(3):983-6. PubMed ID: 4031873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of methods for the determination of beta-aspartylglycine in fecal supernatants of leukemic patients treated with antimicrobial agents.
    Welling GW
    J Chromatogr; 1982 Oct; 232(1):55-62. PubMed ID: 7142339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new glycine containing compound with a blocked amino group from uremic body fluids.
    Zimmerman L; Fürst P; Bergström J; Jörnvall H
    Clin Nephrol; 1980 Sep; 14(3):107-11. PubMed ID: 7418276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical effects on germ-free mice of association with several strains of anaerobic bacteria.
    Welling GW; Groen G; Tuinte JH; Koopman JP; Kennis HM
    J Gen Microbiol; 1980 Mar; 117(1):57-63. PubMed ID: 7391821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N-monoacetylcystine in uraemic plasma.
    Gejyo F; Ito G; Kinoshita Y
    Clin Sci (Lond); 1981 Mar; 60(3):331-4. PubMed ID: 7237945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestinal absorption of glycine and glycyl-glycine in patients with chronic renal failure.
    Sterner G; Lindberg T; Denneberg T
    Acta Med Scand; 1983; 213(5):375-9. PubMed ID: 6880860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid chromatographic determination of acidic beta-aspartyl and gamma-glutamyl peptides in extracts of rat brain.
    Sandberg M; Li X; Folestad S; Weber SG; Orwar O
    Anal Biochem; 1994 Feb; 217(1):48-61. PubMed ID: 7911284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial purification and characterization of an enzyme involved in the formation of beta-aspartyl dipeptides in rat kidney.
    Tanaka T; Hirai M; Nakajima T
    J Biochem; 1978 Nov; 84(5):1147-53. PubMed ID: 32171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid containing compounds in uremic serum-search for middle molecules by high performance liquid chromatography.
    Kaplan B; Gotfried M; Ravid M
    Clin Nephrol; 1986 Aug; 26(2):66-71. PubMed ID: 3757315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.